SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2383Or maybe, "the share price has not appreciate enough to make all of the optFiloF-4/18/2007
2382They're selling the company because of "dissatisfaction with the compannigel bates-4/18/2007
2381>>MedImmune To Be Sold By Monday -CNBC Last update: 4/18/2007 9:40:02 AM Ntuck-4/18/2007
2380Re: STGN munch by Agilent: shareholder files suit to block the the munch: >&tuck-4/16/2007
2379>>MedImmune Explores Strategic Alternatives<< <i>Activist invnigel bates-4/16/2007
2378Quest Diagnostics to Acquire AmeriPath in a Transaction Valued at $2 Billion Monrichardred-4/16/2007
2377MedImmune Explores Strategic Alternatives Message 23452507sim1-4/13/2007
2376<i>They've been consolidating into medicines and away from non-core buDewDiligence_on_SI-4/12/2007
2375I'm not sure this belongs here, but -- Novartis has raised an additional $5John Metcalf-4/12/2007
2374In light of recent Xolair numbers since the label warning added this quarter -- tuck-4/12/2007
2373Steve,the sadness is easier to take if you own the stock. I do agree it's sarichardred-4/7/2007
2372Munch munch goble goble; biz.yahoo.com Sad to see this one go....... steveSteve Lokness-4/6/2007
2371<b>Addressable market $30.9bil - Market cap. $311.5mil</b> Progen&#Henrik-4/6/2007
2370With the premium involved beforehand to prevent competition. Never saw this comrichardred-4/5/2007
2369bid for BSTE bumped to $90 by Inverness Medical Innovations. Premarket bid and scaram(o)uche-4/5/2007
2368Just noticed that the CEO of Neuro3d is none other than Charles Woler, of Cadus tuck-4/4/2007
2367Bioveris (BIOV) munched by Roche; the end of a long-standing love-hate realtionstuck-4/4/2007
2366Roche to Acquire BioVeris for $21.50 Per Share Wednesday April 4, 9:53 am ET GAnigel bates-4/4/2007
2365Roche Acquires THP in $56.5 Million Deal Monday April 2, 1:30 am ET MOUNTAIN Vscaram(o)uche-4/2/2007
2364Evotec to Acquire Neuro3d Hamburg, Germany | Oxford, UK - Evotec AG (Frankfurt nigel bates-3/29/2007
2363Beckman Coulter to buy Biosite for $1.55 billion Sunday March 25, 6:27 pm ET NErichardred-3/25/2007
2362Takes out a Crucell competitor ?nigel bates-3/22/2007
2361Eisai to buy U.S.'s Morphotek for $325 mln Thu Mar 22, 2007 2:14am ET TOKYOscaram(o)uche-3/22/2007
2360AstraZeneca (SEK390.5 - Outperform) [Carnegie Investment Bank AB] Sector: HealtIcebrg-3/20/2007
2359Don't misuse the thread. If you have something that is consistent with the scaram(o)uche-3/14/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News